PKcTn shared a photo from Flipboard

Twelve-month results from the MAJESTIC trial evaluating the performance of the Eluvia drug-eluting stent demonstrated a primary patency rate of 100% amongst diabetic patients and no target lesion revascularisations in this subgroup. ....http://pkductin.com/en/view-507-

PKcTn Via Flipboard
This image was shared from Flipboard, a fast, beautiful way to flip through the news, photos and updates your friends are sharing on Facebook, Twitter, Flickr, Google+ and Instagram.
Free Download! App Store Badge